2014 KLCSG-NCC Korea practice guideline for the management of hepatocellular carcinoma

Korean Liver Cancer Study Group (KLCSG), National Cancer Center, Korea (NCC)

Research output: Contribution to journalReview article

100 Citations (Scopus)

Abstract

The guideline for the management of hepatocellular carcinoma (HCC) was first developed in 2003 and revised in 2009 by the Korean Liver Cancer Study Group and the National Cancer Center, Korea. Since then, many studies on HCC have been carried out in Korea and other countries. In particular, a substantial body of knowledge has been accumulated on diagnosis, staging, and treatment specific to Asian characteristics, especially Koreans, prompting the proposal of new strategies. Accordingly, the new guideline presented herein was developed on the basis of recent evidence and expert opinions. The primary targets of this guideline are patients with suspicious or newly diagnosed HCC. This guideline provides recommendations for the initial treatment of patients with newly diagnosed HCC.

Original languageEnglish
Pages (from-to)267-317
Number of pages51
JournalGut and Liver
Volume9
Issue number3
DOIs
Publication statusPublished - 2015 Jan 1

Fingerprint

Practice Management
Korea
Practice Guidelines
Hepatocellular Carcinoma
Guidelines
Expert Testimony
Liver Neoplasms
Therapeutics
Neoplasms

Keywords

  • Carcinoma, hepatocellular
  • Guidelines
  • Management

ASJC Scopus subject areas

  • Hepatology
  • Gastroenterology

Cite this

Korean Liver Cancer Study Group (KLCSG), & National Cancer Center, Korea (NCC) (2015). 2014 KLCSG-NCC Korea practice guideline for the management of hepatocellular carcinoma. Gut and Liver, 9(3), 267-317. https://doi.org/10.5009/gnl14460

2014 KLCSG-NCC Korea practice guideline for the management of hepatocellular carcinoma. / Korean Liver Cancer Study Group (KLCSG); National Cancer Center, Korea (NCC).

In: Gut and Liver, Vol. 9, No. 3, 01.01.2015, p. 267-317.

Research output: Contribution to journalReview article

Korean Liver Cancer Study Group (KLCSG) & National Cancer Center, Korea (NCC) 2015, '2014 KLCSG-NCC Korea practice guideline for the management of hepatocellular carcinoma', Gut and Liver, vol. 9, no. 3, pp. 267-317. https://doi.org/10.5009/gnl14460
Korean Liver Cancer Study Group (KLCSG), National Cancer Center, Korea (NCC). 2014 KLCSG-NCC Korea practice guideline for the management of hepatocellular carcinoma. Gut and Liver. 2015 Jan 1;9(3):267-317. https://doi.org/10.5009/gnl14460
Korean Liver Cancer Study Group (KLCSG) ; National Cancer Center, Korea (NCC). / 2014 KLCSG-NCC Korea practice guideline for the management of hepatocellular carcinoma. In: Gut and Liver. 2015 ; Vol. 9, No. 3. pp. 267-317.
@article{dfaeaa23d80444e39ebf411ecdcfbe0b,
title = "2014 KLCSG-NCC Korea practice guideline for the management of hepatocellular carcinoma",
abstract = "The guideline for the management of hepatocellular carcinoma (HCC) was first developed in 2003 and revised in 2009 by the Korean Liver Cancer Study Group and the National Cancer Center, Korea. Since then, many studies on HCC have been carried out in Korea and other countries. In particular, a substantial body of knowledge has been accumulated on diagnosis, staging, and treatment specific to Asian characteristics, especially Koreans, prompting the proposal of new strategies. Accordingly, the new guideline presented herein was developed on the basis of recent evidence and expert opinions. The primary targets of this guideline are patients with suspicious or newly diagnosed HCC. This guideline provides recommendations for the initial treatment of patients with newly diagnosed HCC.",
keywords = "Carcinoma, hepatocellular, Guidelines, Management",
author = "{Korean Liver Cancer Study Group (KLCSG)} and {National Cancer Center, Korea (NCC)} and Park, {Joong Won} and Lee, {Joon Hyeok} and Suh, {Kyung Suk} and Chung, {Jin Wook} and Jinsil Seong and Lee, {June Sung} and Tak, {Won Young} and Bae, {Si Hyun} and Yeon, {Jong Eun} and Choi, {Moon Seok} and Kim, {Yoon Jun} and Lim, {Young Suk} and Kim, {Ji Hoon} and Kim, {Do Young} and Kim, {Hwi Young} and Kim, {Bo Hyun} and Lim, {Ho Yeong} and Kim, {Kyung Sik} and Kim, {Seong Hoon} and Choi, {Gi Hong} and Dong-Sik Kim and Kim, {Jong Man} and Cho, {Jai Young} and Lee, {Hae Won} and Yi, {Nam Joon} and Lee, {Jeong Min} and Koh, {Young Hwan} and Kim, {Hyun Beom} and Kim, {Young Kon} and Lee, {Min Woo} and Choi, {Jin Young} and Lee, {Seung Soo} and Shin, {Ji Hoon} and Cho, {Sung Bum} and Cho, {Yun Ku} and Kim, {Tae Hyun} and Kim, {Mi Sook} and Kim, {Jin Hee} and Park, {Hee Chul} and Kay, {Chul Seung} and Yoon, {Won Sup} and Chie, {Eui Kyu}",
year = "2015",
month = "1",
day = "1",
doi = "10.5009/gnl14460",
language = "English",
volume = "9",
pages = "267--317",
journal = "Gut and Liver",
issn = "1976-2283",
publisher = "Joe Bok Chung",
number = "3",

}

TY - JOUR

T1 - 2014 KLCSG-NCC Korea practice guideline for the management of hepatocellular carcinoma

AU - Korean Liver Cancer Study Group (KLCSG)

AU - National Cancer Center, Korea (NCC)

AU - Park, Joong Won

AU - Lee, Joon Hyeok

AU - Suh, Kyung Suk

AU - Chung, Jin Wook

AU - Seong, Jinsil

AU - Lee, June Sung

AU - Tak, Won Young

AU - Bae, Si Hyun

AU - Yeon, Jong Eun

AU - Choi, Moon Seok

AU - Kim, Yoon Jun

AU - Lim, Young Suk

AU - Kim, Ji Hoon

AU - Kim, Do Young

AU - Kim, Hwi Young

AU - Kim, Bo Hyun

AU - Lim, Ho Yeong

AU - Kim, Kyung Sik

AU - Kim, Seong Hoon

AU - Choi, Gi Hong

AU - Kim, Dong-Sik

AU - Kim, Jong Man

AU - Cho, Jai Young

AU - Lee, Hae Won

AU - Yi, Nam Joon

AU - Lee, Jeong Min

AU - Koh, Young Hwan

AU - Kim, Hyun Beom

AU - Kim, Young Kon

AU - Lee, Min Woo

AU - Choi, Jin Young

AU - Lee, Seung Soo

AU - Shin, Ji Hoon

AU - Cho, Sung Bum

AU - Cho, Yun Ku

AU - Kim, Tae Hyun

AU - Kim, Mi Sook

AU - Kim, Jin Hee

AU - Park, Hee Chul

AU - Kay, Chul Seung

AU - Yoon, Won Sup

AU - Chie, Eui Kyu

PY - 2015/1/1

Y1 - 2015/1/1

N2 - The guideline for the management of hepatocellular carcinoma (HCC) was first developed in 2003 and revised in 2009 by the Korean Liver Cancer Study Group and the National Cancer Center, Korea. Since then, many studies on HCC have been carried out in Korea and other countries. In particular, a substantial body of knowledge has been accumulated on diagnosis, staging, and treatment specific to Asian characteristics, especially Koreans, prompting the proposal of new strategies. Accordingly, the new guideline presented herein was developed on the basis of recent evidence and expert opinions. The primary targets of this guideline are patients with suspicious or newly diagnosed HCC. This guideline provides recommendations for the initial treatment of patients with newly diagnosed HCC.

AB - The guideline for the management of hepatocellular carcinoma (HCC) was first developed in 2003 and revised in 2009 by the Korean Liver Cancer Study Group and the National Cancer Center, Korea. Since then, many studies on HCC have been carried out in Korea and other countries. In particular, a substantial body of knowledge has been accumulated on diagnosis, staging, and treatment specific to Asian characteristics, especially Koreans, prompting the proposal of new strategies. Accordingly, the new guideline presented herein was developed on the basis of recent evidence and expert opinions. The primary targets of this guideline are patients with suspicious or newly diagnosed HCC. This guideline provides recommendations for the initial treatment of patients with newly diagnosed HCC.

KW - Carcinoma, hepatocellular

KW - Guidelines

KW - Management

UR - http://www.scopus.com/inward/record.url?scp=84928811506&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84928811506&partnerID=8YFLogxK

U2 - 10.5009/gnl14460

DO - 10.5009/gnl14460

M3 - Review article

C2 - 25918260

AN - SCOPUS:84928811506

VL - 9

SP - 267

EP - 317

JO - Gut and Liver

JF - Gut and Liver

SN - 1976-2283

IS - 3

ER -